Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp403 | Osteoporosis: treatment | ECTS2013

Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis

Makras Polyzois , Polyzos Stergios , Papatheodorou Athanasios , Kokkoris Panagiotis , Chatzifotiadis Daniel , Anastasilakis Athanasios

Purpose: Denosumab is a new potent antiresorptive treatment of osteoporosis that can potentially induce a compensatory increase of parathyroid hormone (PTH) levels. We aimed to evaluate the alteration of PTH 1 and 6 months after denosumab’s administration (60 mg) with different regimens of calcium and vitamin D (Ca/D) supplementation, as well as the association of PTH with serum Ca and bone markers.Methods: This was a prospective, multicenter, study...

ba0001pp488 | Other diseases of bone and mineral metabolism | ECTS2013

Circulating RANKL is not a reliable biomarker for bone loss in primary hyperparathyroidism

Grigorie Daniel , Sucaliuc Alina , Neacsu Elena , Militaru Roxana , Diaconescu Alina , Ivan Mirela

Introduction: The aim was to examine serum levels of RANKL, OPG and TNF-α before and after curative surgery (PTX) in patients with primary hyperparathyroidism, and their relationship to bone turnover and bone loss.Patients and methods: A 46 patients with rather severe primary hyperparathyroidism (mean PTH=196 pg/ml, mean total Ca=11.4 mg/dl, spine osteoporosis in 50%, hip osteoporosis in a third) mean age of 63.3±12.3 years, 41 women/five males...

ba0002p24 | (1) | ICCBH2013

Effects of endurance training on somatic growth in a rat model of chronic kidney disease related growth retardation

Landau Daniel , Guterman Maayan , Yahalom Ari , Troib Ariel , Rabkin Ralph , Segev Yael

Objectives: CKD in children is associated with suppressed body growth. Physical activity has been previously shown to increase expression of IGF1 signaling in muscles of rats with CKD, but the effects of this intervention on bone tissue have not been investigated yet. The purpose of this study was to examine the effects of aerobic exercise on CKD related bone disease.Methods: Twenty-day old/50 g male rats underwent a two step subtotal nephrectomy (Nx) or...

ba0002p80 | (1) | ICCBH2013

Osteogenesis imperfecta and short stature: effect of sclerostin antibody treatment in oim/oim mice

Cardinal Mickael , Nyssen-Behets Catherine , Ominsky Mike , Devogelaer Jean-Pierre , Manicourt Daniel H

Introduction: Osteogenesis imperfecta (OI) is characterized by low bone mass, skeletal fragility and, frequently, short stature. We previously showed in oim/oim mice that sclerostin inhibition increased bone mass, mineral content and strength. Here, we compared the body length and the sizes of long bones, head and vertebrae between oim/oim and wildtype mice and analyzed the effect of sclerostin antibody (Scl-Ab) on these parameters.Materials and methods:...

ba0003oc3.5 | Osteoclasts, gastric hormones and HIF | ECTS2014

Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical microarchitectures and bone strength.

Mieczkowska Aleksandra , Mansur Sity , Flatt Peter , Irwin Nigel , Chappard Daniel , Mabilleau Guillaume

Objectives: A role for the gut hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) in controlling bone mass and strength has previously been reported. However, lack of one gut hormone is compensated by an elevated sensitivity to the other in single receptor knockout mice. As such the exact role of GIP and GLP-1 in bone is unclear. The aims of the present study were to assess bone mass and strength in mice with functional deletion of ...

ba0003pp100 | Cancer and bone: basic, translational and clinical | ECTS2014

Bone quality of metaplastic woven bone of mixed metastases: a FTIRI analysis

Chappard Daniel , Bouvard Beatrice , Masson Charles , Legrand Erick , Audran Maurice , Mabilleau Guillaume , Mieczkowska Aleksandra

Objectives: Most osteolytic tumors are in fact mixed and contain an osteoblastic component associated with the predominant osteolytic areas. This metaplastic woven bone can be evidenced on X-rays as blurred white areas but is always evidenced by histological analysis even in the absence of radiological expression. Metaplastic bone formation reflects the activation of new osteoblasts, the stimulation of the dormant lining cells due to the release of growth factors buried in the...

ba0003pp258 | Osteoporosis: pathophysiology and epidemiology | ECTS2014

Socio-economic status and hip fracture risk: a region-wide ecological study

Reyes Carlen , Javaid M Kassim , Cooper Cyrus , Diez-Perez Adolfo , Prieto-Alhambra Daniel

Purpose: To determine the association between socio-economic status (SES) and risk of hip fracture.Methods: Retrospective cohort study. We used a population database which contains primary care and hospital inpatient records of over >5 million people. Anyone registered in this database in 2009–2012 and resident in an urban area was eligible. Main measures: a validated SES composite index (accounting for proportion of unemployed, insufficiently e...

ba0003pp289 | Osteoporosis: pathophysiology and epidemiology | ECTS2014

The impact of common comorbidities (as measured using the Charlson index) on hip fracture risk in elderly men: a population-based cohort study

Reyes Carlen , Nogues Xavier , Cooper Cyrus , Diez-Perez Adolfo , Prieto-Alhambra Daniel

Purpose: To determine whether and which co-morbidities (amongst those included in the Charlson co-morbidity index) confer an increased risk of hip fracture amongst elderly men.Methods: We conducted a population-based cohort study using a population database which contains primary care and hospital inpatient records of over >2 million people. All men aged ≥65 years registered on 1/1/2007 were followed up until 31/12/2009. Both exposure (co-morbi...

ba0004p81 | (1) | ICCBH2015

Liver growth hormone receptor signaling in chronic kidney disease related growth retardation: the role of suppressor of cytokine signaling 2

Hilal Rawan Abu , Assadi Mohammad Hani , Chen Yu , Medrano Juan , Rabkin Ralph , Segev Yael , Landau Daniel

Introduction: Children with chronic kidney disease (CKD) who suffer from growth retardation have usually normal circulating GH but low IGF1, suggesting GH resistance. We have previously shown in growth retarded CKD rats an increase in suppressor of cytokine signaling 2 (SOCS2) levels, a key negative regulator of GH signaling. SOCS2 spontaneously mutated (HG) mice show an exaggerated body growth and increased bone mass. We investigated growth and GH receptor (GHR) signaling in ...